Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
Premi Fundació Banc Sabadell 2026
L’investigador ICREA Marc Güell rep el XXI Premi Fundació Banc Sabadell a la Investigació Biomèdica La Fundació Banc Sabadell ha…
ERC Advanced grants 2025
Tres recercaires ICREA han rebut l’ajut ERC Advanced Grant del Consell Europeu de la Recerca. Moltes felicitats a l'Eduard Batlle…